Here we explored lipid metabolism defects in CD4 + T-cells from patients with RRMS, with a focus on examining the role of LXRβ-regulated pathways on CD4 + T-cell lipid raft composition and function. This evidence concerns the gene CD4 and relapsing-remitting multiple sclerosis.